Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How I diagnose and treat NPM1-mutated AML
Brunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
Blood (2020) Vol. 137, Iss. 5, pp. 589-599
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 138
Liquid–liquid phase separation in tumor biology
Xuhui Tong, Rong Tang, Jin Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 131
Current status and future perspectives in targeted therapy of NPM1-mutated AML
Roberta Ranieri, Giulia Pianigiani, Sofia Sciabolacci, et al.
Leukemia (2022) Vol. 36, Iss. 10, pp. 2351-2367
Open Access | Times Cited: 65
A concise review on the molecular genetics of acute myeloid leukemia
Devipriya Padmakumar, Radhakrishnan Chandraprabha Vineetha, Preethi Gopinath, et al.
Leukemia Research (2021) Vol. 111, pp. 106727-106727
Closed Access | Times Cited: 62
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia
Brunangelo Falini, Maria Paola Martelli
American Journal of Hematology (2023) Vol. 98, Iss. 3, pp. 481-492
Closed Access | Times Cited: 34
NPM 1 Mutations in AML—The Landscape in 2023
Naman Sharma, Jane L. Liesveld
Cancers (2023) Vol. 15, Iss. 4, pp. 1177-1177
Open Access | Times Cited: 26
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML
Maria Paola Martelli, Roberta Rossi, Alessandra Venanzi, et al.
Blood (2021) Vol. 138, Iss. 25, pp. 2696-2701
Open Access | Times Cited: 46
Overlapping features of therapy-related and de novo NPM1-mutated AML
Jad Othman, Manja Meggendorfer, Enrico Tiacci, et al.
Blood (2022) Vol. 141, Iss. 15, pp. 1846-1857
Open Access | Times Cited: 33
NPM1‐mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions
Brunangelo Falini
American Journal of Hematology (2023) Vol. 98, Iss. 9, pp. 1452-1464
Open Access | Times Cited: 20
Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML
Brunangelo Falini, Richard Dillon
Blood Cancer Discovery (2023) Vol. 5, Iss. 1, pp. 8-20
Open Access | Times Cited: 17
A venetoclax and azacitidine bridge‐to‐transplant strategy for NPM1‐mutated acute myeloid leukaemia in molecular failure
Chiara Sartor, L. Brunetti, Ernesta Audisio, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 3, pp. 599-607
Open Access | Times Cited: 16
Tumour‐derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8‐mediated creatine import in NPM1‐mutated acute myeloid leukaemia
Meixi Peng, Jun Ren, Yipei Jing, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 13
Open Access | Times Cited: 33
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine
Hartmut Döhner, Andrew H. Wei, Gail J. Roboz, et al.
Blood (2022) Vol. 140, Iss. 15, pp. 1674-1685
Open Access | Times Cited: 27
Targeted therapy in NPM1-mutated AML: Knowns and unknowns
Rong Wang, Pan Xu, Linlin Chang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML
Giulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Blood Advances (2022) Vol. 6, Iss. 22, pp. 5938-5949
Open Access | Times Cited: 24
Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
Lynn Chin, Chantelle Ye Gwen Wong, Harinder Gill
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3161-3161
Open Access | Times Cited: 14
NPM1 mutation frequency and protein in Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasms
Hanan Hamdan, Alexa J. Siddon, Maximiliano Ramia de, et al.
Human Pathology (2025), pp. 105766-105766
Closed Access
NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
Fabio Forghieri, Vincenzo Nasillo, Ambra Paolini, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 8975-8975
Open Access | Times Cited: 36
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML
Ilaria Gionfriddo, Lorenzo Brunetti, Federica Mezzasoma, et al.
Leukemia (2021) Vol. 35, Iss. 9, pp. 2552-2562
Open Access | Times Cited: 32
Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field
Brunangelo Falini, Sofia Sciabolacci, Lorenza Falini, et al.
Leukemia (2021) Vol. 35, Iss. 11, pp. 3113-3126
Open Access | Times Cited: 30
The RIG-I–NRF2 axis regulates the mesenchymal stromal niche for bone marrow transplantation
Qi Lou, Kaizheng Jiang, Quanhui Xu, et al.
Blood (2022) Vol. 139, Iss. 21, pp. 3204-3221
Open Access | Times Cited: 18
Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears
Jacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, et al.
Blood Advances (2023) Vol. 8, Iss. 1, pp. 70-79
Open Access | Times Cited: 9
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
Nour Moukalled, Myriam Labopin, Jurjen Versluis, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 3, pp. 360-369
Closed Access | Times Cited: 3
Acute Myeloid Leukaemia
FRACP Barbara J. Bain MB BS, FRCP Mike Leach MB ChB
(2024), pp. 141-270
Closed Access | Times Cited: 3
The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation
Yi Wang, Andres Quesada, Zhuang Zuo, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 198-198
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top